Skip Header

14 results for author:"Skapek S.X." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (2)

p19Arf represses platelet-derived growth factor receptor beta by transcriptional and posttranscriptional mechanisms.

Widau R.C., Zheng Y., Sung C.Y., Zelivianskaia A., Roach L.E., Bachmeyer K.M., Abramova T., Desgardin A., Rosner A., Cunningham J.M. et al.

Mol. Cell. Biol. 32:4270-4282(2012) · Mapped (30)

Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development.

Freeman-Anderson N.E., Zheng Y., McCalla-Martin A.C., Treanor L.M., Zhao Y.D., Garfin P.M., He T.C., Mary M.N., Thornton J.D., Anderson C. et al.

Development 136:2081-2089(2009) · Mapped (35)

p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.

Saab R., Rodriguez-Galindo C., Matmati K., Rehg J.E., Baumer S.H., Khoury J.D., Billups C., Neale G., Helton K.J., Skapek S.X.

Cancer Res. 69:440-448(2009) · Mapped (21)

Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor.

Thornton J.D., Swanson D.J., Mary M.N., Pei D., Martin A.C., Pounds S., Goldowitz D., Skapek S.X.

Invest. Ophthalmol. Vis. Sci. 48:491-499(2007) · Mapped (7)

The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.

Thornton J.D., Silva R.L., Martin A.C., Skapek S.X.

Cell Cycle 4:1316-1319(2005) · Mapped (7)

Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.

Silva R.L., Thornton J.D., Martin A.C., Rehg J.E., Bertwistle D., Zindy F., Skapek S.X.

EMBO J. 24:2803-2814(2005) · Mapped (14)

Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.

Martin A.C., Thornton J.D., Liu J., Wang X., Zuo J., Jablonski M.M., Chaum E., Zindy F., Skapek S.X.

Invest. Ophthalmol. Vis. Sci. 45:3387-3396(2004) · Mapped (3)

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Zindy F., Williams R.T., Baudino T.A., Rehg J.E., Skapek S.X., Cleveland J.L., Roussel M.F., Sherr C.J.

Proc. Natl. Acad. Sci. U.S.A. 100:15930-15935(2003) · Mapped (7)

The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.

McKeller R.N., Fowler J.L., Cunningham J.J., Warner N., Smeyne R.J., Zindy F., Skapek S.X.

Proc. Natl. Acad. Sci. U.S.A. 99:3848-3853(2002) · Mapped (18)

Persistent expression of cyclin D1 disrupts normal photoreceptor differentiation and retina development.

Skapek S.X., Lin S.C., Jablonski M.M., McKeller R.N., Tan M., Hu N., Lee E.Y.

Oncogene 20:6742-6751(2001) · Mapped (4)

The proliferative and apoptotic activities of E2F1 in the mouse retina.

Lin S.C., Skapek S.X., Papermaster D.S., Hankin M., Lee E.Y.

Oncogene 20:7073-7084(2001) · Mapped (11)

Cloning and characterization of a novel Kruppel-associated box family transcriptional repressor that interacts with the retinoblastoma gene product, RB.

Skapek S.X., Jansen D., Wei T.-F., McDermott T., Huang W., Olson E.N., Lee E.Y.-H.P.

J. Biol. Chem. 275:7212-7223(2000) · UniProtKB (2) · Mapped (1)

Genes in the RB pathway and their knockout in mice.

Lin S.C., Skapek S.X., Lee E.Y.

Semin. Cancer Biol. 7:279-289(1996) · Mapped (16)

Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.

Skapek S.X., Rhee J., Kim P.S., Novitch B.G., Lassar A.B.

Mol. Cell. Biol. 16:7043-7053(1996) · Mapped (14)

to top of page·

Page 1 of 1